Ashish Kacholia stock jumps 4% after company’s net profit increases by 200% YoY

Synopsis:
Acutaas Chemicals reported Rs. 207 crore revenue in Q1 FY26, with strong YoY growth in profit and margins, despite QoQ declines, and announced a strategic semiconductor joint venture in South Korea in the quarter.

During Wednesday’s trading session, shares of a leading global manufacturer of advanced pharmaceutical intermediates and speciality chemicals surged nearly 4.5 percent on BSE, after reporting a net profit growth of around 200 percent YoY in Q1 FY26.

At 02:44 p.m., the shares of Acutaas Chemicals Limited were trading in the green at Rs. 1,215 on BSE, up by around 4 percent, as against its previous closing price of Rs. 1,167.7, with a market cap of Rs. 9,947 crores. The stock has delivered positive returns of around 81 percent in the last one year, and has gained by over 6 percent in the last one month.

What’s the News

According to the latest regulatory filings on the stock exchanges, Acutaas Chemicals Limited announced the financial results for Q1 FY26 on Wednesday during market hours.

For Q1 FY26, Acutaas Chemicals reported a revenue from operations of Rs. 207 crores, marking around a 33 percent QoQ decline compared to Rs. 308.5 crores in Q4 FY25, but a year-on-year increase of about 17 percent from Rs. 176.7 crores recorded in Q1 FY25.

The company’s net profit for the quarter stood at Rs. 44 crores, reflecting a marginal decline of around 30 percent QoQ compared to Rs. 63 crores in Q4 FY25, but a year-on-year impressive rise of about 200 percent from Rs. 14.7 crores recorded in Q1 FY25. At the operating level, EBITDA stood at Rs. 51 crores during Q1 FY26, improving by 72.4 percent YoY but declining by 40 percent QoQ.

Additionally, Gross Profit Margin increased to 53.2 percent in Q1 FY26 from 42.1 percent recorded in Q1 FY25, while EBITDA Margin grew from 16.7 percent to 24.6 percent, over the same period.

During the same quarter, the company also announced its entry into a joint venture in South Korea, a strategic move that brings it closer to key semiconductor markets and enhances its portfolio with differentiated, high-value products tailored for this segment. With growing customer engagement across COMO, battery chemicals, and semiconductors, Acutaas Chemicals enters FY26 with strong momentum and confidence in achieving 25 percent growth alongside improved margins. As per the company’s shareholding pattern of June 2025, the ace investor Ashish Kacholia holds a 1.17 percent stake in Acutaas Chemicals.

Acutaas Chemicals Limited, formerly known as Ami Organics Limited, is a speciality chemicals manufacturer serving a wide range of industries, including pharmaceuticals, semiconductors, battery chemicals, personal care, agrochemicals, and fine chemicals. Its core strength lies in the research-driven development and manufacturing of advanced pharmaceutical intermediates used in both regulated and generic APIs, as well as intermediates for New Chemical Entities (NCEs). 

Written by Shivani Singh

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Ashish Kacholia stock jumps 4% after company’s net profit increases by 200% YoY appeared first on Trade Brains.